Meissner will deliver a hands-on demonstration of their CryoVault™ Platform for bulk drug substance at BioProduction Congress. The event, which is now part of CPhI Worldwide in Frankfurt, Germany will take place at Messe Frankfurt on 5-7 November 2019. Meissner’s Director of Business Development for Europe, Thomas Vandromme, will present at Meissner’s booth #120F06 on Thursday 7th November at 13h35. The demonstration will focus on Meissner’s unique solution for freezing/thawing of bulk drug substance (BDS).
Attendees are invited to participate in the demonstration and experience the filtration and single-use system solutions on display. Innovative technologies and product enhancements will be highlighted including, single-use Fill & Finish capabilities, the CryoVault™ Freeze and Thaw Platform for BDS, discussed in the presentation, and the AccuFlux® integrity tester, which can perform diffusive flow, water intrusion, pressure hold and bubble point tests for critical process applications, including post-use integrity testing CryoVault™ biocontainers.
BioProduction Congress is one of six sub-events at the 30th Annual CPhI Worldwide conference. This is the first year that BioProduction Congress will be a part of this event, which is expected to bring together 45,000 attendees over the 3-day conference. For more information, visit www.meissner.com.